X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-02 | RNA | Boyce Sarah | Pres, CEO | S - Sale+OE | $26.25 | -28,000 | 112,117 | -20% | -$734,919 | |||||
| DM | 2024-03-08 | RNA | Boyce Sarah | Pres, CEO | S - Sale+OE | $21.70 | -112,000 | 112,117 | -50% | -$2,430,392 | |||||
| D | 2024-03-01 | RNA | Boyce Sarah | Pres, CEO | S - Sale+OE | $20.13 | -84,000 | 112,117 | -43% | -$1,691,306 | |||||
| D | 2024-01-22 | RNA | Boyce Sarah | Pres, CEO | S - Sale+OE | $10.13 | -5,092 | 44,008 | -10% | -$51,582 | |||||
| DM | 2023-02-01 | RNA | Boyce Sarah | Pres, CEO | S - Sale+OE | $24.35 | -50,000 | 53,352 | -48% | -$1,217,727 | |||||
| M | 2022-11-09 | OABI | Boyce Sarah | Dir | P - Purchase | $2.82 | +36,000 | 88,437 | +69% | +$101,397 | |||||
| DM | 2022-08-24 | RNA | Boyce Sarah | Pres, CEO | S - Sale+OE | $22.88 | -49,900 | 0 | -100% | -$1,141,614 | |||||
| D | 2022-08-15 | RNA | Boyce Sarah | Pres, CEO | S - Sale+OE | $22.47 | -100 | 0 | -100% | -$2,247 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |